Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 638,000 | 652,000 | 695,000 | 679,000 | 717,000 |
| Cost of Goods | 202,000 | 200,000 | 217,000 | 213,000 | 238,000 |
| Gross Profit | 436,000 | 452,000 | 478,000 | 466,000 | 479,000 |
| Operating Expenses | 298,000 | 320,000 | 296,000 | 297,000 | 262,000 |
| Operating Income | 138,000 | 132,000 | 182,000 | 169,000 | 217,000 |
| Interest Expense | 14,000 | 16,000 | 19,000 | 21,000 | 22,000 |
| Other Income | -42,000 | 3,000 | 7,000 | 8,000 | -33,000 |
| Pre-tax Income | 82,000 | 119,000 | 170,000 | 156,000 | 162,000 |
| Income Tax | 22,000 | 34,000 | 48,000 | 50,000 | 55,000 |
| Net Income Continuous | 60,000 | 85,000 | 122,000 | 106,000 | 107,000 |
| Net Income | $60,000 | $85,000 | $122,000 | $106,000 | $107,000 |
| EPS Basic Total Ops | 0.08 | 0.11 | 0.15 | 0.13 | 0.13 |
| EPS Basic Continuous Ops | 0.07 | 0.10 | 0.15 | 0.13 | 0.13 |
| EPS Diluted Total Ops | 0.08 | 0.11 | 0.15 | 0.13 | 0.13 |
| EPS Diluted Continuous Ops | 0.07 | 0.10 | 0.15 | 0.13 | 0.13 |
| EBITDA(a) | $138,000 | $132,000 | $182,000 | $169,000 | $395,000 |